MedPath
HSA Product

SPIOLTO® RESPIMAT® RE-USABLE SOLUTION FOR INHALATION 2.5 MICROGRAM / 2.5 MICROGRAM

Product approved by Health Sciences Authority (SG)

Basic Information

SPIOLTO® RESPIMAT® RE-USABLE SOLUTION FOR INHALATION 2.5 MICROGRAM / 2.5 MICROGRAM

SOLUTION

Regulatory Information

SIN15890P

February 25, 2020

Prescription Only

Therapeutic

RESPIRATORY (INHALATION)

August 10, 2023

May 30, 2025

XR03AL06

Company Information

BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.

BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.

Active Ingredients

Olodaterol hydrochloride eqv olodaterol

Strength: 0.0025 mg/actuation

Detailed Information

Contraindications

**4.3 Contraindications** SPIOLTO RESPIMAT re-usable is contraindicated in patients with hypersensitivity to tiotropium or olodaterol or to any of the excipients. SPIOLTO RESPIMAT re-usable is also contraindicated in patients with a history of hypersensitivity to atropine or its derivatives, e.g. ipratropium or oxitropium.

Indication Information

**4.1 Therapeutic indications** SPIOLTO RESPIMAT re-usable is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

© Copyright 2025. All Rights Reserved by MedPath